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Objective: To ascertain a viral vector-based short hairpin RNA (shRNA) capable of reducing the inter-
leukin-1b (IL-1b) transcript in osteoarthritis (OA)-prone chondrocytes and detect corresponding changes
in the expression patterns of several critical disease mediators.
Methods: Cultured chondrocytes from 2-month-old Hartley guinea pigs were screened for reduction of the
IL-1b transcript following plasmid-based delivery of U6-driven shRNA sequences. A successful plasmid/
shRNA knockdown combination was identiﬁed and used to construct an adeno-associated virus serotype 5
(AAV5) vector for further evaluation. Relative real-time reverse transcription polymerase chain reaction (RT-
PCR) was used to quantify in vitro transcript changes of IL-1b and an additional nine genes following
transduction with this targeting knockdown vector. To validate in vitro ﬁndings, this AAV5 vector was
injected into one knee, while either an equivalent volume of saline vehicle (three animals) or non-targeting
control vector (three animals) were injected into opposite knees. Fold differences and subsequent percent
gene expression levels relative to control groupswere calculated using the comparative CT (2DDCT) method.
Results: Statistically signiﬁcant decreases in IL-1b expression were achieved by the targeting knockdown
vector relative to both the mock-transduced control and non-targeting vector control groups in vitro. Tran-
script levels of anabolic transforming growth factor-b (TGF-b) were signiﬁcantly increased by use of this
targeting knockdown vector. Transduction with this targeting AAV5 vector also signiﬁcantly decreased the
transcript levels of key inﬂammatory cytokines [tumor necrosis factor-a (TNF-a), IL-2, IL-8, and IL-12] and
catabolic agents [matrix metalloproteinase (MMP)13, MMP2, interferon-g (IFN-g), and inducible nitrous
oxide synthase (iNOS)] relative to both mock-transduced and non-targeting vector control groups. In vivo
application of this targeting knockdown vector resulted in a >50% reduction (P¼ 0.0045) or >90%
(P¼ 0.0001) of the IL-1b transcript relative to vehicle-only or non-targeting vector control exposed cartilage,
respectively.
Conclusions: Successful reduction of the IL-1b transcript was achieved via RNA interference (RNAi)
techniques. Importantly, this alteration signiﬁcantly inﬂuenced the transcript levels of several major
players involved in OA pathogenesis in the direction of disease modiﬁcation. Investigations to charac-
terize additional gene expression changes inﬂuenced by targeting knockdown AAV5 vector-based
diminution of the IL-1b transcript in vivo are warranted.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Multiple molecular and biomechanical factors induce signaling
cascades that lead to extracellular matrix (ECM) destruction and
osteoarthritis (OA). Speciﬁcally, interleukin-1b (IL-1b) is consideredA.L. Bertone, Department of
t, The Ohio State University,
-292-3526.
ertone).
s Research Society International. Pa primary instigator of OA1. In cell culture and explants, IL-1b inhibits
maintenance of the ECM network2 and directly provokes protease-
induced cartilage destruction3. IL-1b is also a mediator of inﬂam-
mation andmay be involvedwith painmechanisms in joints affected
by OA4. Thus, it is recognized that inhibiting the biological activities
of IL-1b could modify or alleviate the disease at several levels5.
In vitro and in vivo efforts to reduce or block IL-1b have been
demonstrated using diacerein/rhein or IL-1 receptor antagonist
protein (IRAP) in experimental OA4,6e18. Although these studies
suggest that IL-1b is important for the development of secondaryOA,ublished by Elsevier Ltd. All rights reserved.
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compared to wild-type litter mates1. Use of knockout mice to study
the pathogenesis of OA is valuable but suffers from drawbacks,
including potential for compensatory gene expression1. Alternatively,
RNA interference (RNAi) technology can be used to generate loss-of-
function phenotypes without complications associated with tradi-
tional knockout animals19. Targeted, localized reduction of gene
products implicated in naturally-occurring OA provides the oppor-
tunity to deﬁne contributions of speciﬁc molecular pathways to the
disease and offers potential as a therapeutic strategy20. Further,
delivery of small RNAs capable of inciting cellular knockdown
machinery via lowly immunogenic and persistent viral vectors, such
as recombinant adeno-associated virus (AAV), have emerged as
capable systems for application in musculoskeletal disorders21. AAV-
based delivery of RNAi constructs has been successful in cell culture
and animal model systems20 and holds promise in the context of OA.
Currently, there are minimal reports using RNAi to study the
pathogenesis of OA. It was our hypothesis that reducing the IL-1b
transcript via delivery of a plasmid-based and, subsequently, an
AAV vector-based short hairpin RNA (shRNA) sequence would alter
expression patterns of additional mediators implicated in OA.
Importantly, this knockdownwas investigated, and sustained, with
and without inﬂammatory insults instigated by either lipopoly-
saccharide (LPS) or exogenous recombinant human (rh)IL-1b.
Moreover, evidence is provided that reduction of IL-1b may be
plausible in vivo using this validated tool.
Materials & methods
All procedures were approved by the university’s Institutional
Laboratory Animal Care and Use Committee and performed in
accordance with the National Institutes of Health (NIH) Guide for
the Care and Use of Laboratory Animals. Cartilage was aseptically
harvested from knees of ﬁve 2-month-old male Hartley guinea pigs
(Charles River Laboratories, Wilmington, MA), pooled, and minced.
Cells were isolated following a 6-hour digestion in 0.2% collagenase
I (Gibco, Grand Island, NY) and expanded in standard culture
conditions in Dulbecco’s modiﬁed Eagle medium (DMEM) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS),
29.2 mg/ml L-glutamine, 50 U penicillin/ml, and 50 U streptomycin/
ml until >95% conﬂuent. Chondrocytes were implemented prior to
their fourth passage. Six 2-month-old male animals were used for
the in vivo study.
Plasmid screening
Experiments to screen plasmids containing potential knockdown
shRNA sequences were performed in triplicate. The selected plasmid
allowed simultaneous expression of shRNA via the U6 promoter and
CMV-driven enhanced green ﬂuorescent protein (GFP) expression
[Fig. 1(A)] and is intended for making single-stranded AAV vectors.
Ten shRNA knockdown sequences and one non-targeting sequence
[Fig. 1(A)] were conceived using RNAi Block-IT Designer (Invitrogen,
Carlsbad, CA) and cloned into plasmids using standard techniques.
Chondrocytes (2.5105) were seeded into T25 ﬂasks (Greiner Bio-
One, Monroe, NC) and allowed to reachw50% conﬂuency, at which
time cultured cells were transfected using FuGENE6 Transfection
reagent (Roche Applied Science, Indianapolis, IN) in serum- and
antibiotic-free DMEM according to recommendations at
a reagent:DNA ratio of 3:1. Media containing transfection complexes
were removed 24-h post-exposure; new non-supplemented
Minimum Essential Media, Eagle (MEM-E) (Mediatech, Herndon,
VA) was added, either with or without 1 mg/ml LPS (Escherichia coli
O111:B4; SigmaeAldrich, St. Louis, MO) for an additional 24-h. Cells
were monitored for onset of GFP using ﬂuorescent microscopy. Alltreatment groups were removed from culture ﬂasks 48-h post-
transfection for ﬂow cytometry. Once a successful plasmid/shRNA
knockdown sequence combination was identiﬁed, culture experi-
ments to detect additional transcript changes were performed in
triplicate.
In vitro knockdown
The selected plasmid/shRNA knockdown sequence combination
(shRNA#1) and non-targeting control plasmid were used to produce
IL-1b knockdown and non-targeting control AAV serotype 5 (AAV5)
vectors, respectively, by the Viral Vector Core at Nationwide
Children’s Hospital (Columbus, OH) using the standard triple-
transfection method22. Vector titration to determine DNase-
resistant particles (DRP) of each vector was performed as described
using quantitative real-time PCR23. Chondrocytes were seeded and
cultured, as above, until w75% conﬂuent, at which time triplicate
culture replicateswere exposed to one of three treatments: (1)mock-
transduction procedure, no vector control (C); (2) non-targeting
vector control (NTC); or (3) targeting knockdown targeting knock-
down vector (TV). In all groups, cells were exposed to vectors (or an
equivalent volume of media for C) at a cell:DRP titer of 1:100,000 in
serum-free DMEM containing 2 mM doxorubicin hydrochloride
(Calbiochem, La Jolla, CA) for 2-h, followed by addition of 10% FBS24.
Preliminary work identiﬁed this protocol and cell:DRP titer ratio as
the lowest and most efﬁcacious method able to achieve >75%
transduction efﬁciency. After a total of 8 h, media was removed and
replaced with supplemented DMEM. Cells were monitored for onset
of GFP, which began 48-h post-vector exposure, using ﬂuorescent
microscopyandﬂowcytometry. To evaluate gene expression changes
with and without inﬂammatory insults, cells were exposed to one of
three media conditions 24-h prior to harvest: (1) fresh MEM-E, only;
(2) LPS in MEM-E, as described; or (3) 10 ng/ml rhIL-1b (Roche,
Mannheim, Germany) in MEM-E. All treatment groups were
collected from culture ﬂasks 48-h post-onset of GFP [Fig. 2(A)] to
allow adequate time for transcript knockdown to occur.
In vivo knockdown
Three 2-month-old male Hartley guinea pigs aseptically
received TV (11012 DRP in 100 ml of phosphate buffered saline
(PBS)) in one knee, while the opposite knee was injected with an
equivalent volume of PBS. An additional three guinea pigs received
TV in one knee or an identical vector dose of NTC in the other knee.
Administered vector doses were consistent with other peer-
reviewed manuscripts25,26. Two months post-injection, animals
were humanely euthanized; cartilage was collected from the
patella and patellar surface of the femur for RNA extraction to
detect IL-1b transcript expression, as described below. One-step
reverse transcription polymerase chain reaction (RT-PCR)
(Invitrogen, Carlsbad, CA) conﬁrmed GFP expression using speciﬁc
primers (Table I; Euroﬁns MWG Operon, Huntsville, AL); glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) served as a positive
control. Universal cycling parameters were employed for cDNA
construction and ampliﬁcation. Products were run in a 1% agarose
gel containing ethidium bromide and visualized under ultraviolet
(UV) light.
Flow cytometry
Chondrocytes were analyzed for and, for plasmid-transfected
cells, separated by GFP using the i-Cyt Reﬂection (i-Cyt, Champaign,
IL). Green ﬂuorescence was excited by an argon 488 nm laser and
detected using a 520/30 nm bandpass ﬁlter on the 520 parameter;
positive cells were collected for analysis.
Fig. 1. (A) Schematic representation of the AAV plasmid (top) used to deliver selected shRNA sequences (bottom) to cultured guinea pig chondrocytes. Sequences that signiﬁcantly
reduced IL-1b transcript expression in chondrocytes as detected by real-time RT-PCR are shown in corresponding colors in (D). (B) RT-PCR products in agarose gel (left) and positive
immunohistochemistry staining (right, arrows) conﬁrm expression of IL-1b at the transcript and protein levels, respectively, in 2-month-old primary cultured chondrocytes up to
the fourth passage and in situ chondrocytes. (C) Representative example of ﬂow cytometry data (top graphs) to conﬁrm and sort GFPþ chondrocytes (bottom photomicrographs,
200 ﬁnal magniﬁcation) in plasmid-transfected samples. (D) Signiﬁcant reduction of the IL-1b transcript (mean percent gene expression levels 95% conﬁdence intervals) relative
to a non-targeting control shRNA was detected in guinea pig chondrocytes receiving the color matched shRNA sequences in (A) delivered via plasmid. Within each media condition
(control or LPS), fold differences and subsequent percent gene expression levels relative to C were calculated using the comparative CT (2DDCT) method. Data (triplicate assay values
for triplicate culture samples) were analyzed using one-way ANOVA for comparison among groups followed by pairwise comparisons using Tukey 95% conﬁdence intervals;
signiﬁcant differences are indicated.
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Total RNA was isolated from in vitro and in vivo chondrocytes via
the NucleoSpin RNA XS kit (Clontech, Mountain View, CA), which
includes DNase treatment. cDNA was made using Taqman Reverse
Transcription Reagents (Applied Biosystems, Foster City, CA) andqRT-PCR, complete with dissociation curve, was performed in trip-
licate for each gene of interest under each triplicate experimental
condition (triplicate assay values for triplicate culture samples for
in vitro work; triplicate assay values for N¼ 6 animals) using Power
SYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK)
and guinea pig speciﬁc primers (Table I) on the ABI Prism 7000
Table I
Guinea pig speciﬁc primers used for real-time RT-PCR
Transcript of interest Primer sequences (50e30)
GAPDH* F: GTATCGTGGAAGGACTCATGACC
R: GTTGAAGTCACAGGACACAACCT
eGFP* F: CATGATATAGACGTTGTGGCTGTTG
R: AAGCTGACCCTGAAGTTCATCTGC
IL-1b* F: ACGCCTGGTGTTGTCTGAC
R: GGGAACTGAGCGGATTC
18S ribosomal RNAy F: TGCATGGCCGTTCTTAGTTG
R: AGTTAGCATGCCAGAGTCTCGTT
IL-2z F: CTTAAGCTCTCCAAAGCA
R: CCATCTCTTCAGAAATTCCAC
IL-4x F: CATCGGCATTTTGAACGAGGTCA
R: CTATCGATGAATCCAGGCATCG
IL-6x F: CAGCCCTGAGAAAGGAGACAT
R: AATCTGAGGTGCCCATGCTAC
IL-8y F: GGCAGCCTTCCTGCTCTCT
R: CAGCTCCGAGACCAACTTTGT
IL-10z F: GGCACGAACACCCAGTCTGA
R: TCACCTGCTCCACTGCCTTG
IL-12z F: TCTGAGCCGGTCACAACTGC
R: AGGCGCTGTCCTCCTGACAC
Collagenase 1 (MMP1)k F: AGGTTATCCCAAAATGAT
R: TGCAGTTGAACCAGCTATT
Aggrecanase (MMP2)x F: AGGGCACCTCCTACAACAGC
R: CAGTGGACATAGCGGTCTCG
Collagenase 3 (MMP13)k F: TTCTGGCACATGCTTTTCCTC
R: GGTTGGGGTCTTCATCTCCTG
TGF-by F: CATCGATATGGAGCTGGTGAAG
R: GCCGTAATTTGGACAGGATCTG
TNF-ay F: CCTACCTGCTTCTCACCCATACC
R: TTGATGGCAGAGAGAAGGTTGA
IFN-gy F: ATTTCGGTCAATGACGAGCAT
R: GTTTCCTCTGGTTCGGTGACA
iNOS (LT){ F: TGGATGCAACCCCATTGTC
R: CCCGCTGCCCCAGTTT
* Primers designed by KSS. All amplicons were sequenced to conﬁrm gene tran-
script speciﬁcity.
y Allen SS, et al. Infect Immun 2003;71(8):4271e7.
z Yamada H, et al. Exp Anim 2005;54(2):163e172.
x Oh C, et al. Am J Obstet Gynecol 2008;199(1):78.e1e6.
k Huebner JL, et al. Arthritis Rheum 1998;41(5):877e90.
{ Thompson L, et al. Pediatr Res 2009;65(2):188e92.
Fig. 2. (A) Representative photomicrographs of AAV5 vector-transduced guinea pig
chondrocytes (200 ﬁnal magniﬁcation). (B) In vitro AAV5 vector-based reduction of the
IL-1b transcript via delivery of the selected shRNA #1 sequence, as indicated in Fig. 1. The
targeting knockdown vector (TV) consistently demonstrated signiﬁcantly reduced IL-1b
transcript levels relative to the mock-transduced, no vector control (C) and the non-
targeting vector control (NTC). Within each media condition (control, LPS, or IL-1b),
fold differences and subsequent percent gene expression levels (mean 95% conﬁdence
intervals) relative to C were calculated using the comparative CT (2DDCT) method. Data
(triplicate assay values for triplicate culture samples) were analyzed using one-way
ANOVA for comparison among groups (N, NTC, and TV) followed by pairwise compar-
isons using Tukey 95% conﬁdence intervals; signiﬁcant differences are indicated.
K.S. Santangelo, A.L. Bertone / Osteoarthritis and Cartilage 19 (2011) 1449e14571452Sequence Detection System (Applied Biosystems, Foster City, CA)
according to published standards and recommendations27. 18s
ribosomal RNA and GAPDH were used as separate endogenous
controls towhich each gene of interest was normalized. Results were
consistent between housekeeping genes; GAPDH comparisons are
represented. To conﬁrm absence of ampliﬁcation, reactions were
repeated using larger starting amounts of cDNA. Fold changes and
subsequent percent gene expression levels relative to designated
control groups were calculated using the comparative CT (2DDCT)
method. For plasmid-transfection analyses, potential targeting
shRNA plasmids of interest were compared to the non-targeting
shRNA control sequence within each media. To stringently evaluate
TV, all comparative CT values were normalized relative to C within
each media (MEM-E, LPS in MEM-E, or rhIL-1b in MEM-E). In vivo
comparative CT values for TV were compared to control knee carti-
lage receiving saline-only or NTC injection.
Statistical analysis
In vitro (triplicate assay values for triplicate culture samples) and
in vivo (triplicate assay values for N¼ 6 animals) DCT values for each
gene of interest under each experimental condition were analyzed
fore and passedeGaussian distribution and homogeneous variance
using the KolmogoroveSmirnov normality test28. Flow cytometry
and relative percent expression qRT-PCR data (directly converted
from fold changes) were expressed as mean 95% conﬁdence
interval. For in vitro data, relative qRT-PCR data within and between
media conditions were analyzed for each individual gene of interest
by one-way analysis of variance (ANOVA) for comparison among
groups (C, NTC, and TV) followed by pairwise comparisons using
Tukey 95% conﬁdence intervals. Paired t-testswere utilized for in vivocomparisons within C/TV and NTC/TV groups; statistical differences
in DCT values were not detected within or between animals. All
analyses were performed using the Minitab statistical software
program (State College, PA) with a statistical signiﬁcance of P< 0.05.
Results
Preliminary studies to detect IL-1b in 2-month-old guinea pig
chondrocytes at transcript and protein levels via RT-PCR and
immunohistochemistry, respectively, conﬁrmed presence in host
tissue and cultured cells up to the fourth passage [Fig. 1(B)]. Flow
cytometry revealed that 28.15 2.44% of plasmid-transfected cells
were positive for GFP [Fig. 1(C)], which is consistent with other lipid-
based DNA delivery methods for primary chondrocytes29. Relative
qRT-PCR identiﬁed three of ten shRNA sequences that signiﬁcantly
decreased IL-1b transcript levels relative to the non-targeting control
plasmid [Fig. 1(D)]. In control media, shRNA #1 achieved a degree of
knockdown (89.42 0.38%) that was greater (P¼ 0.004) than the
reduction provided by shRNA#2 and #3 and was anticipated to
inﬂuence expression of other genes of interest. This knockdown
(97.18 2.72%) was maintained (P¼ 0.002) during active LPS chal-
lenge [Fig. 1(D)].
The inﬂuence of IL-1b knockdown on expression of other medi-
ators was comparable between plasmid-transfected and vector-
transduced chondrocytes; expression changes for the latter are
presented.
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Flow cytometry on pilot studies revealed that 87.50 4.55% of
chondrocytes expressed GFP 48 h following initial 2-h application of
AAV5 vectors [Fig. 2(A)]. Ampliﬁcation was not detected for
the following transcripts (Table I): collagenase I/matrix
metalloproteinase-1 (MMP1); IL-4; IL-6; and IL-10 (data not shown).
IL-1b transcript
Media inﬂuence. Exogenous LPS increased (P< 0.001) transcript
expression of IL-1b relative to control media (Table II). Exogenous
rhIL-1b, however, decreased (P¼ 0.007) expression of IL-1b relative
to control media (Table II), and treatment with either AAV5 vector
signiﬁcantly reduced this expression further (Fig. 2).
Transcript changes. Signiﬁcant decreases in IL-1b expression were
achieved by TV relative to C and NTC groups in all media [Fig. 2(B)].
Speciﬁcally, IL-1b was reduced to 48.00 2.54%, 37.251.44%, and
6.50 0.29% relative percent expression levels in control, LPS, and
rhIL-1bmedia, respectively. This knockdown is particularly striking
given that NTC increased (P< 0.001) transcript levels of IL-1b in
control and LPS media. Although exogenous rhIL-1b statistically
decreased IL-1b expression (which was further exaggerated in the
presence of AAV5 vector), TV continued to result in a decreased IL-
1b transcript level relative to C (P< 0.001) and NTC (P¼ 0.03)
control groups.
Inﬂammatory mediators
Media inﬂuence. Overall, exogenous LPS and rhIL-1b signiﬁcantly
increased transcript expression of inﬂammatory genes of interest
relative to control media (Table II). IL-2, however, was only detected
in media containing rhIL-1b [Fig. 3(B)] and LPS media reduced
expression of IL-12 to below detection limits [Fig. 3(D)].
Inﬂuence of RNAi. Transcript changes associated with inﬂammatory
agents were signiﬁcantly affected following exposure to TV and
NTC, and these changes were often inﬂuenced by ambient media
that was present. In general, transduction with TV statistically
decreased transcript levels of key inﬂammatory cytokines relative
to C and NTC groups. Findings relevant to individual genes and
media are elucidated below.
Tumor necrosis factor-a (TNF-a). In control and rhIL-1b media,
TNF-a transcript levels were signiﬁcantly reduced by TV relative to
C and NTC control groups [Fig. 3(A)]. In rhIL-1b media, TNF-a was
decreased (P¼ 0.002) by NTC relative to C, but reduction continued
to be most signiﬁcant by TV. In LPS media, however, TNF-a was
increased (P< 0.001) in TV and NTC groups compared to C. Further,
TNF-a was greater (P< 0.001) in TV treated cells than NTC-treated
cells.Table II
DCT valuesD standard deviation (normalized to GAPDH) and corresponding percent exp
conditions relative to control media
Transcript Control media LPS med
DCTDSD % SD DCTDSD % SD
IL-1b 2.82 0.12 100 8.67 1.22 0.10 303.4
TNF-a 7.22 0.14 100 9.38 1.20 0.10 6,489.3
IL-2 ND e ND
IL-8 4.62 0.13 100 8.72 0.11 0.10 2,294.3
IL-12 5.10 0.14 100 9.63 ND
TGF-b 4.91 0.10 100 7.17 3.50 0.12 37.8
MMP13 2.94 0.11 100 7.92 3.19 0.08 7,003.4
MMP2 ND e 4.32 0.11
IFN-g 8.12 0.14 100 9.25 8.71 0.02 151.5
iNOS 3.16 0.14 100 9.34 2.42 0.08 167.0
ND¼Amplicon not detected; NA¼ Comparative CT (2DDCT) method not applicable; P vIL-2. IL-2 was detected only in rhIL-1b media treatment groups
[Fig. 3(B)]. IL-2 was increased (P< 0.001) by TV compared to NTC
and C control groups.
IL-8. Expression patterns observed for the IL-8 transcript were
inﬂuenced by media conditions [Fig. 3(C)]. In control media, IL-8
levels were increased (P< 0.001) by NTV relative to TV and C. No
statistical differencewas found between the latter two treatments. In
LPS media, however, TV and NTC groups were increased (P< 0.001)
relative to C. Exogenous rhIL-1bmedia, on the other hand, decreased
(P< 0.001) the IL-8 transcript in the presence of either AAV5 vector,
with a signiﬁcant reduction (P¼ 0.02) induced by TV.
IL-12. IL-12 was present in control and rhIL-1bmedia, only, and
was statistically lower in TV relative to C and NTC control groups in
both conditions [Fig. 3(D)]. In control media, IL-12 was increased
(P< 0.001) in NTC relative to C, while it was decreased (P¼ 0.002)
by NTC relative to C in the presence of rhIL-1b.
Control media. In general, transcript levels of inﬂammatory
cytokines in control media were either below detection or
demonstrated a signiﬁcant decrease in the presence of TV (Fig. 3).
Interestingly, IL-8 and IL-12 were signiﬁcantly increased when
transduced by NTC relative to C.
LPS media. In LPS media, IL-2 and IL-12 were below detection
limits. TNF-a [Fig. 3(A)] and IL-8 [Fig. 3(C)], however, showed
increased (P< 0.001) cytokine transcript expression in the pres-
ence of either the TV or NTC AAV5 vector. TNF-a, in particular, was
further increased (P< 0.001) in TV treated cells exposed to LPS
media relative to NTC cells.
rhIL-1b media. All transcripts of interest, except for IL-2, were
statistically decreased by TV in exogenous rhIL-1b media (Fig. 3).
For IL-2, transduction with TV resulted in an increase (P< 0.001) in
IL-2 transcription relative to C and NTC control groups [Fig. 3(B)].
Anabolic and catabolic agents
Media inﬂuence. Overall, exogenous LPS and rhIL-1b signiﬁcantly
decreased transcript expression of transforming growth factor-
b (TGF-b) relative to control media (Table II). LPS and rhIL-1b treat-
ment, however, statistically increased transcript numbers of all
catabolic agents investigated (Table II). Gelatinase A/MMP2was only
detected in control media following exposure to NTC [Fig. 5(B)].
Inﬂuence of RNAi. In general, transcript levels of anabolic TGF-
b were signiﬁcantly increased by use of TV relative to C and NTC
control groups. Transduction with TV also statistically decreased
transcript levels of catabolic agents relative to C and NTC. Results
pertinent to individual genes and media are discussed below.
TGF-b. In LPS and rhIL-1b media, expression of TGF-b was
signiﬁcantly increased by TV relative to NTC (Fig. 4). Of note, TV
resulted in an increase (P< 0.001) in TGF-b relative to C in LPS
media. In control media, both AAV5 vectors statistically increasedression (mean standard deviation) of transcripts of interest in inﬂammatorymedia
ia rhIL-1b media
DCTDSD % SD
1 20.26 (P< 0.001) 3.60 0.14 58.24 5.39 (P¼ 0.007)
4 434.57 (P< 0.001) 2.22 0.12 3,244.67 263.10 (P< 0.001)
e 8.66 0.14 NA
3 168.74 (P< 0.001) 1.11 0.11 1,147.16 84.21 (P< 0.001)
e 4.70 0.14 131.19 11.45 (P¼ 0.009)
9 3.03 (P¼ 0.003) 3.12 0.10 28.71 1.92 (P¼ 0.002)
8 377.79 (P< 0.001) 1.4 0.10 2,082.15 139.44 (P< 0.001)
NA 6.00 0.10 NA
7 2.09 (P¼ 0.005) 9.60 0.08 282.84 15.26 (P< 0.001)
1 9.01 (P¼ 0.003) 2.22 0.11 191.85 14.09 (P< 0.001)
alues are indicated.
Fig. 3. Associated transcript expression changes for inﬂammatory mediators TNF-a
(A), IL-2 (B), IL-8 (C), and IL-12 (D) following in vitro AAV5 vector-based reduction of
the IL-1b transcript. Within each media condition (control, LPS, or IL-1b), fold differ-
ences and subsequent percent gene expression levels (mean 95% conﬁdence inter-
vals) for the targeting knockdown vector (TV) and non-targeting vector control (NTC)
relative to the mock-transduced, no vector control (C) were calculated using the
comparative CT (2DDCT) method. Data (triplicate assay values for triplicate culture
samples) were analyzed using one-way ANOVA for comparison among groups (N, NTC,
and TV) followed by pairwise comparisons using Tukey 95% conﬁdence intervals;
signiﬁcant differences are indicated.
Fig. 4. In vitro reduction of the IL-1b transcript inﬂuences transcript expression of the
anabolic agent TGF-b. Within each media condition (control, LPS, or IL-1b), fold
differences and subsequent percent gene expression levels (mean 95% conﬁdence
intervals) for the targeting knockdown vector (TV) and non-targeting vector control
(NTC) relative to the mock-transduced, no vector control (C) were calculated using the
comparative CT (2DDCT) method. Data (triplicate assay values for triplicate culture
samples) were analyzed using one-way ANOVA for comparison among groups (N, NTC,
and TV) followed by pairwise comparisons using Tukey 95% conﬁdence intervals;
signiﬁcant differences are indicated.
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between these two AAV5 vectors was not present.
Collagenase III/MMP13. In all media, MMP13 was signiﬁcantly
reduced following transduction with TV [Fig. 5(A)]. In contrast,
MMP13 was statistically increased by NTC relative to C in control
and LPS media. In rhIL-1b media, MMP13 was decreased in both
AAV5 vector treatment groups relative to C, but TV continued to
demonstrate fewer (P¼ 0.03) MMP13 transcripts relative to NTC.
Gelatinase A/MMP2 and interferon-g (IFN-g). Expression patterns
forMMP2 and IFN-gwere similar. In both cases, gene expressionwas
signiﬁcantly decreased by TV relative to C and NTC control groups in
LPS and rhIL-1bmedia [Fig. 5(B and C)]. Further, the IFN-g transcript
was reduced (P< 0.001) by TV relative to C in control media. While
NTC statistically decreased transcript levels relative to C in LPS-
treated chondrocytes, MMP2 and IFN-g transcripts were signiﬁ-
cantly increased by NTC in rhIL-1b media.
Inducible nitrous oxide synthase (iNOS). In control and rhIL-1b
media, iNOSwas below detection limits following treatmentwith TV
[Fig. 5(D)]. For LPS media, iNOS was not different between TV and C
groups; transcript levels, however, were signiﬁcantly higher
(P< 0.001) in the NTC group. In all media, transduction with NTC
resulted in statistically increased expression levels of iNOS relative to
TV and C.
Control media. In control media, treatment with either AAV5
vector resulted in a statistical increase in TGF-b transcript numbers
(Fig. 4). With the exception of MMP2, for which expression was
only detected following NTC treatment, all catabolic genes were
signiﬁcantly reduced by TV relative to C and NTC (Fig. 5). Of note,
transcript numbers for all catabolic genes were increased when
transduced by NTC relative to C.
LPS media. In LPS media, expression of TGF-b was increased
(P< 0.001) by TV relative to C and NTC (Fig. 4). Except for iNOS,
transcript levels of all catabolic agents in this media were either
below detection or demonstrated statistical decreases following
exposure to TV (Fig. 5).
rhIL-1b media. Treatment with either AVV5 vector resulted in
signiﬁcantly reduced TGF-b transcript numbers relative to C
(Fig. 4). Importantly, expression of TGF-bwas decreased (P¼ 0.04)
by TV relative to NTC in this media. Transcript levels of all cata-
bolic agents following exposure to TV demonstrated statistical
reductions relative to C and NTC (Fig. 5). Except for MMP13,
remaining catabolic mediators were also signiﬁcantly increased
by NTC relative to C.
Fig. 5. In vitro reduction of the IL-1b transcript inﬂuences transcript expression of the
catabolic mediators MMP13 (A), MMP2 (B), IFN-g (C), and iNOS (D). In general,
transductionwith the targeting knockdown vector (TV) signiﬁcantly reduced the genes
of interest in all media conditions relative to the mock-transduced, no vector control
(C) and non-targeting vector control (NTC). Within each media condition (control, LPS,
or IL-1b), fold differences and subsequent percent gene expression levels (mean 95%
conﬁdence intervals) for TV and NTC relative to C were calculated using the compar-
ative CT (2DDCT) method. Data (triplicate assay values for triplicate culture samples)
were analyzed using one-way ANOVA for comparison among groups (N, NTC, and TV)
followed by pairwise comparisons using Tukey 95% conﬁdence intervals; signiﬁcant
differences are indicated.
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A decrease (P¼ 0.0045) in IL-1b transcript level (44.25 8.16%)
was attained in cartilage in vivo by TV relative to PBS-only,
contralateral control knees [Fig. 6(A)]. A reduction (P¼ 0.0001) in
IL-1b (5.50 8.00%) was also present in cartilage exposed to TV
relative to contralateral NTC-treated knees. Importantly, reporter
gene expression was detected in cartilage harvested from knees
injected with TV or NTC [Fig. 6(B)].
Discussion
We recently described the temporal expression and tissue
distributionof IL-1b throughprogressionof primaryOA in two strains
of guinea pigswith varying disease propensity30. Persistent IL-1bwas
found in cartilage, menisci, synovium, and subchondral bone in
OA-prone animals at 120 and 180 days, while OA-resistant animals
demonstrated a signiﬁcant decrease in expression, a ﬁnding that
suggested a relationship between IL-1b and premature disease inci-
dence in the former strain. These ﬁndings prompted the current
work, which had a primary aim of identifying a tool capable of
reducing IL-1b-mediated pathways such that evidence of its mech-
anistic contribution to OA could be determined.
To our knowledge, this is the ﬁrst study to demonstrate AAV5
vector-based reduction of the IL-1b transcript viaU6-driven shRNA-
mediated RNAi in OA-prone guinea pig chondrocytes. Importantly,
cells in vitrowere exposed to two standard inﬂammatory agents, LPS
and rhIL-1b, to demonstrate persistent knockdown during biologi-
cally relevant scenarios where an upregulation of the IL-1b tran-
script is anticipated. This knockdown also resulted in statistically
signiﬁcant changes in gene expression of other factors implicated in
OA pathogenesis in all media conditions. Of note, key inﬂammatory
(TNF-a, IL-2, IL-8, and IL-12) and catabolic agents (MMP13, MMP2,
IFN-g, and iNOS)were signiﬁcantly decreased byTV relative toC and
NTC, while an anabolic factor (TGF-b) was statistically increased.Fig. 6. (A) In vivo transduction in six 2-month-old guinea pigs (GP) with the targeting
knockdown (TV) AAV5 vector resulted in statistically signiﬁcant reductions in IL-1b
transcript expression relative to saline-only control (PBS; GP1e3) or non-targeting
control vector (NTC; GP4e6) exposed cartilage in opposite knees. Fold differences
and subsequent percent gene expression levels (mean 95% conﬁdence intervals) for
TV relative to PBS or NTC were calculated in the six animals (N¼ 3 in the group
receiving either TV or PBS and N¼ 3 in the group receiving TV or NTC). For each
treatment condition and individual animal, triplicate assay replicates for the gene of
interest were determined via real-time RT-PCR utilizing the comparative CT (2DDCT)
method and analyzed using paired t-tests; signiﬁcant differences are indicated. (B)
Expression of GFP was conﬁrmed by RT-PCR in each knee injected with TV (shown) or
NTC (data not shown); GAPDH served as a positive internal control.
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reduced >50% relative to contralateral control cartilage and >90%
relative to NTC-exposed cartilage. A long-term study, including
additional timepoints and an increased sample size, is merited to
pursue associated genes of interest that may be inﬂuenced by this
degree of in situ transcript reduction in cartilage, as well as other
relevant joint tissue.
In general, transcript patterns observed following targeted
reduction of IL-1b via RNAi in guinea pig chondrocytes coincided
with ﬁndings exhibited following in vitro treatment with diacer-
ein/rhein or IRAP, particularly in regards to MMPs, iNOS, and
TGF-b. For example, diacerein/rhein has been shown to decrease
secreted protein levels of proMMPs-1, -3, and -13 in cultured
rabbit articular chondrocytes exposed to rhIL-1a at a concentra-
tion of 1 ng/ml6. Human OA cartilage treated with exogenous
rhIRAP reduces these same mediators at the transcript level7.
Further, in equine synoviocytes transduced with an adenoviral
vector carrying a coding region for IRAP, MMP13mRNA expression
was signiﬁcantly lower compared to non-transduced controls8.
Interestingly, however, one study evaluating diacerein did not
detect a signiﬁcant difference in MMP13 in media of human OA
chondrocytes stimulated by rhIL-1b (10 U/ml), but differences in
experimental design may account for this discrepancy9. Reduction
of iNOS mRNA and NO release from bovine chondrocytes10,
human OA chondrocytes in alginate beads11, and LPS-stimulated
(1 mg/ml) human OA cartilage12 have also been observed
following application of diacerein/rhein in a dose-dependent
manner. The study utilizing human cells in alginate beads also
demonstrated that, in media containing 1010 M rhIL-1b, rhein did
not signiﬁcantly modify IL-8 production11. Enhanced expression of
TGF-b1 and TGF-b2 mRNA and total mature TGF-b protein were
observed in bovine chondrocytes treated with 10 ng/ml IL-1b
(species source not indicated)13, as well as rabbit chondrocytes14.
Corroboration of our ﬁndings with other work provides evidence
that use of vector-based shRNA to reduce the effective concen-
tration of the IL-1b transcript in chondrocytes may be equivalent
to established methods.
TNF-a in LPS media and IL-2 in rhIL-1bmedia were statistically
increased by TV relative to C and NTC controls. Although there are
no studies that have previously discussed the effects of IL-1b
antagonism on IL-2 expression, a study using equine synoviocytes
in basal media andmedia containing 10 ng/ml IL-1b demonstrated
that TNF-a was signiﬁcantly increased following transduction
with an adenoviral vector containing a coding region for IRAP,
particularly when exposed to the latter treatment15. Additional
work is necessary to establish mechanisms leading to increases in
these inﬂammatory cytokines with concurrent IL-1b reduction
and in relation to speciﬁc media. Our ﬁndings emphasize complex
and opposing effects that ambient environmental stimulators
have on gene expression in the face of identical treatment
protocols.
Our study also demonstrated that NTC signiﬁcantly increased
transcript levels of IL-1b, TNF-a, IL-8, IL-12, MMP13, MMP2, IFN-g,
and iNOS in various media relative to C and TV. AAV, itself, is known
to be a weak innate immunogen, and cytokine and chemokine
responses in transduced tissues are limited and highly transient16.
For instance, intravenous administration of an AAV vector resulted in
rapid induction of TNF-amRNA inmurine liver cells that returned to
normal levels within 6 h17. As such, the signiﬁcance of inﬂammatory
transcript changes noted in our in vitro study may not have relevant
in vivo implications. The inﬂuence that a non-targeting control AAV5
vector may have on catabolic agents, however, is unknown and
merits consideration.
Published qRT-PCR primer sets for MMP1, IL-4, IL-6, and IL-10
were validated in our laboratory and tested throughout thisstudy, but did not result in detectable amplicons. These ﬁndings
may, indeed, indicate that these mediators were not undergoing
transcription, but further work continues to trouble-shoot assay
conditions and assess alternate primer options. We were particu-
larly interested in MMP1, as differing effects related to IL-1b
antagonists have been reported. In one study, rhein reduced tran-
script levels of this catabolic agent in rhIL-1b (10 ng/ml)
stimulated bovine chondrocytes18, while another study using rhIL-
1b (10 U/ml) treated human OA chondrocytes were exposed to
diacerein and a signiﬁcant reversal in MMP1 levels was not
detected in culture media9. In contrast, exogenous hrIRAP has
shown a dose-dependent decrease in MMP1 mRNA in the canine
model of experimental OA19. Further, IL-6 production in human
chondrocytes was statistically decreased by rhein in unconditioned
media but was not affected by diacerein in media containing
1010 M rhIL-1b11.
Media was collected from treatment groups to correlate
transcript changes to detectable protein levels. Given need to
exhaustively validate reagent cross-reactivity with guinea pig
epitopes, as well as account for inherent lability of several
mediators31, studies persist to correlate mRNA data with protein
data via Western blot and/or enzyme-linked immunosorbent
assay (ELISA) analysis. To date, our laboratory has tested several
commercially available ELISA kits designed for use with human,
mouse, and rat epitopes, but guinea pig IL-1b levels continue to
be below the detection limit of these assays.
In conclusion, a plasmid- and AAV5 vector-based shRNA sequence
was capable of reducing the IL-1b transcript in OA-prone chon-
drocytes in vitro with and without active inﬂammatory challenges.
Differential gene expression of known disease mediators occurred as
a result of knockdown, with inﬂuences in the direction of beneﬁcial
modiﬁcation of OA pathogenesis. Importantly, in vivo application of
TV resulted in a signiﬁcant reduction of the IL-1b transcript relative to
PBS-only or NTC-exposed cartilage. Investigations to characterize
expression changes inﬂuenced by reduction of the IL-1b transcript
in vivo are warranted.
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